Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease-Reference-Cited by-同舟云学术

Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease

Published:2003-11 Issue:11 Volume:15 Page:1165-1170
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:European Journal of Gastroenterology & Hepatology

Author:

von Tirpitz Christian,Epp Sonja,Klaus Jochen,Mason Richard,Hawa Gerhard,Brinskelle-Schmal Natascha,Hofbauer Lorenz C,Adler Guido,Kratzer Wolfgang,Reinshagen Max

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference40 articles.

1. A controlled study of bone mineral density in patients with inflammatory bowel disease.

2. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis

3. The Incidence of Fracture among Patients with Inflammatory Bowel Disease: A Population-Based Cohort Study

4. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of fecal biomarkers in individuals with inflammatory bowel disease;Expert Review of Molecular Diagnostics;2024-06-02

2. Osteoporosis Complications in Crohn's Disease Patients: Factors, Pathogenesis, and Treatment Outlines;Cureus;2021-12-21

3. The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids;Arthritis & Rheumatology;2021-09-17

4. Osteoporosis associated with gastrointestinal disorders: celiac and inflammatory bowel diseases;Marcus and Feldman's Osteoporosis;2021

5. Osteoprotegerin (OPG) pathways in bone diseases and its application in therapeutic perspectives;Biointerface Research in Applied Chemistry;2020-02-03